A hypothesis based on the role of HER2 signaling in PFKFB3 expression and its contribution to BC progression was reported by O’Neal J. et al. [56], who showed that enhanced HER2 expression elevated glycolysis by increasing the activity of PFKFB3. This evidence concerns the gene PFKFB3 and breast cancer.